Cited by 1,652Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Disease Prevention

The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.

Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms

Abstract

Endothelial dysfunction contributes to cardiovascular diseases, including hypertension, atherosclerosis, and coronary artery disease, which are also characterized by insulin resistance. Insulin resistance is a hallmark of metabolic disorders, including type 2 diabetes mellitus and obesity, which are also characterized by endothelial dysfunction. Metabolic actions of insulin to promote glucose disposal are augmented by vascular actions of insulin in endothelium to stimulate production of the vasodilator nitric oxide (NO). Indeed, NO-dependent increases in blood flow to skeletal muscle account for 25% to 40% of the increase in glucose uptake in response to insulin stimulation. Phosphatidylinositol 3-kinase-dependent insulin-signaling pathways in endothelium related to production of NO share striking similarities with metabolic pathways in skeletal muscle that promote glucose uptake. Other distinct nonmetabolic branches of insulin-signaling pathways regulate secretion of the vasoconstrictor endothelin-1 in endothelium. Metabolic insulin resistance is characterized by pathway-specific impairment in phosphatidylinositol 3-kinase-dependent signaling, which in endothelium may cause imbalance between production of NO and secretion of endothelin-1, leading to decreased blood flow, which worsens insulin resistance. Therapeutic interventions in animal models and human studies have demonstrated that improving endothelial function ameliorates insulin resistance, whereas improving insulin sensitivity ameliorates endothelial dysfunction. Taken together, cellular, physiological, clinical, and epidemiological studies strongly support a reciprocal relationship between endothelial dysfunction and insulin resistance that helps to link cardiovascular and metabolic diseases. In the present review, we discuss pathophysiological mechanisms, including inflammatory processes, that couple endothelial dysfunction with insulin resistance and emphasize important therapeutic implications.

Overview

Integrity signals

Registry

Crossref · 10.1161/circulationaha.105.563213

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 186 references

Research works printed but not linked: 15

  1. 10.1161/circ.101.13.1539 · DOI
  2. Formoso G Chen H Kim J Montagnani M Consoli A Quon MJ. DHEA mimics acute actions of insulin to stimulate production of both NO and ET-1 via distinct PI 3-kinase- and MAP-kinase-dependent pathways in vascular endothelium. Mol Endocrinol. In press.
  3. 10.1161/circ.100.8.820 · DOI
  4. 10.1161/hyp.34.4.586 · DOI
  5. Renkin EM. Control of microcirculation and blood-tissue exchange. In: Handbook of Physiology: The Cardiovascular System: Microcirculation. Bethesda Md: American Physiological Society; 1984: 627–687.
  6. 10.1161/circ.103.21.2531 · DOI
  7. 10.1161/circ.102.18.2165 · DOI
  8. 10.1161/circ.101.6.676 · DOI
  9. 10.1161/hyp.35.6.1270 · DOI
  10. 10.1161/circ.100.15.1646 · DOI
  11. 10.1161/circ.102.11.1296 · DOI
  12. 10.1161/hyp.26.2.290 · DOI
  13. Potenza MA, Marasciulo FL, Tarquinio M, Quon MJ, Montagnani M. Rosiglitazone improves hypertension in spontaneously hypertensive rats (SHR) by decreasing endothelial MAP kinase signaling and endothelin-1 (ET-1) secretion. Diabetes. 2005; 54 (suppl 1): A320. Abstract.
  14. 10.1161/atvb.21.12.1891 · DOI
  15. 10.1161/atvb.20.6.1595 · DOI

Cited by

Sorted by citations

Items 401–500 of 999

Metadata

Authors
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J.
Affiliations
National Institutes of Health (US)
Venue
Circulation
Published
2006-04-18
Volume
113
Issue
15
Pages
1888-1904
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2126412451
Cited by
1,652
References
186
Citations by year
2026: 68 · 2025: 80 · 2024: 61 · 2023: 55 · 2022: 67 · 2021: 71 · 2020: 67 · 2019: 64 · 2018: 76 · 2017: 70 · 2016: 76 · 2015: 99 · 2014: 96 · 2013: 119 · 2012: 108
FWCI
61.64
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health
  • National Center for Complementary and Alternative Medicine
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
insulin resistance, endothelial dysfunction, nitric oxide, endothelin-1, phosphatidylinositol 3-kinase signaling, glucose uptake, skeletal muscle blood flow, type 2 diabetes, obesity, cardiovascular disease, inflammation, bidirectional relationship
MeSH terms
Animals, Disease Models, Animal, Endothelium, Vascular, Glucose, Hemodynamics, Homeostasis, Humans, Insulin, Insulin Resistance, Signal Transduction, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review